Nuclear receptor coactivators: Master regulators of human health and disease

Annual Review of Medicine

Volumn 65, Issue , 2014, Pages 279-292

  Dasgupta, Subhamoy ^a   Lonard, David M ^a   O'Malley, Bert W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer; Coregulators; Metabolism; Reproduction; Transcriptional cofactors

Indexed keywords

STEROID RECEPTOR COACTIVATOR 1;

CANCER GROWTH; CANCER THERAPY; ENERGY METABOLISM; GENE CONTROL; HUMAN; METASTASIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REPRODUCTION; REVIEW; SRC HOMOLOGY DOMAIN;

ENERGY METABOLISM; GENE EXPRESSION REGULATION; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NUCLEAR RECEPTOR COACTIVATORS; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; REPRODUCTION;

EID: 84894674781     PISSN: 00664219     EISSN: 1545326X     Source Type: Book Series    
DOI: 10.1146/annurev-med-051812-145316     Document Type: Review

References (76)

1. Lonard DM, Kumar R, O'Malley BW. 2010. Minireview: the SRC family of coactivators: an entree to understanding a subset of polygenic diseases? Mol. Endocrinol. 24:279-85
2. O'Malley BW, Malovannaya A, Qin J. 2012. Minireview: nuclear receptor and coregulator proteomics- 2012 and beyond. Mol. Endocrinol. 26:1646-50
3. Tsai MJ, O'Malley BW. 1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63:451-86 (Pubitemid 24218640)
4. Lonard DM, O'Malley BW. 2006. The expanding cosmos of nuclear receptor coactivators. Cell 125:411- 14
5. Onate SA, Tsai SY, Tsai MJ, et al. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-57
6. Lonard DM, O'Malley BW. 2012. Nuclear receptor coregulators: modulators of pathology and therapeutic targets. Nat. Rev. Endocrinol. 8:598-604
7. York B, O'Malley BW. 2010. Steroid receptor coactivator (SRC) family: masters of systems biology. J. Biol. Chem. 285:38743-50
8. Puigserver P, Adelmant G, Wu Z, et al. 1999. Activation of PPARgamma coactivator-1 through transcription factor docking. Science 286:1368-71
9. Petrij F, Giles RH, Dauwerse HG, et al. 1995. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376:348-51
10. Chen D, Ma H, Hong H, et al. 1999. Regulation of transcription by a protein methyltransferase. Science 284:2174-77 (Pubitemid 29297477)
11. Mukherjee A, Amato P, Allred DC, et al. 2007. Steroid receptor coactivator 2 is required for female fertility and mammary morphogenesis: insights from the mouse, relevance to the human. Nucl. Recept. Signal 5:e011
12. Johnson AB, O'Malley BW. 2012. Steroid receptor coactivators 1, 2, and 3: critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapy. Mol. Cell. Endocrinol. 348:430-39
13. Hsia EY, Goodson ML, Zou JX, et al. 2010. Nuclear receptor coregulators as a new paradigm for therapeutic targeting. Adv. Drug Deliv. Rev. 62:1227-37
14. Li C, Wu RC, Amazit L, et al. 2007. Specific amino acid residues in the basic helix-loop-helix domain of SRC-3 are essential for its nuclear localization and proteasome-dependent turnover. Mol. Cell. Biol. 27:1296-308 (Pubitemid 46239813)
15. Xu J, Wu RC, O'Malley BW. 2009. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat. Rev. Cancer 9:615-30
16. Feng Q, HeB, Jung SY, et al. 2009. Biochemical control ofCARM1enzymatic activity by phosphorylation. J. Biol. Chem. 284:36167-74
17. Malovannaya A, Lanz RB, Jung SY, et al. 2011. Analysis of the human endogenous coregulator complexome. Cell 145:787-99
18. Han SJ, Lonard DM, O'Malley BW. 2009. Multi-modulation of nuclear receptor coactivators through posttranslational modifications. Trends Endocrinol. Metab. 20:8-15
19. Borud B, Hoang T, Bakke M, et al. 2002. The nuclear receptor coactivators p300/CBP/cointegratorassociated protein (p/CIP) and transcription intermediary factor 2 (TIF2) differentially regulate PKA-stimulated transcriptional activity of steroidogenic factor 1. Mol. Endocrinol. 16:757-73 (Pubitemid 34297745)
20. Chopra AR, Kommagani R, Saha P, et al. 2011. Cellular energy depletion resets whole-body energy by promoting coactivator-mediated dietary fuel absorption. Cell Metab. 13:35-43
21. Wu RC, Qin J, Hashimoto Y, et al. 2002. Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by I kappa B kinase. Mol. Cell. Biol. 22:3549-61
22. Wu RC, Qin J, Yi P, et al. 2004. Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic responses to multiple cellular signaling pathways. Mol. Cell 15:937-49 (Pubitemid 39277990)
23. Yi P, Wu RC, Sandquist J, et al. 2005. Peptidyl-prolyl isomerase 1 (Pin1) serves as a coactivator of steroid receptor by regulating the activity of phosphorylated steroid receptor coactivator 3 (SRC-3/AIB1). Mol. Cell. Biol. 25:9687-99 (Pubitemid 41507865)
24. Yi P, Feng Q, Amazit L, et al. 2008. Atypical protein kinase C regulates dual pathways for degradation of the oncogenic coactivator SRC-3/AIB1. Mol. Cell 29:465-76 (Pubitemid 351291678)
25. York B, Yu C, Sagen JV, et al. 2010. Reprogramming the posttranslational code of SRC-3 confers a switch in mammalian systems biology. Proc. Natl. Acad. Sci. USA 107:11122-27
26. Long W, Yi P, Amazit L, et al. 2010. SRC-3Delta4 mediates the interaction of EGFR with FAK to promote cell migration. Mol. Cell 37:321-32
27. Long W, Foulds CE, Qin J, et al. 2012. ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion. J. Clin. Invest. 122:1869-80
28. Li C, Liang YY, Feng XH, et al. 2008. Essential phosphatases and a phospho-degron are critical for regulation of SRC-3/AIB1 coactivator function and turnover. Mol. Cell 31:835-49
29. Oh AS, Lahusen JT, Chien CD, et al. 2008. Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by ABL kinase and is required for its activity in cancer cells. Mol. Cell. Biol. 28:6580-93
30. WuRC, FengQ, Lonard DM, et al. 2007. SRC-3 coactivator functional lifetime is regulated by a phosphodependent ubiquitin time clock. Cell 129:1125-40 (Pubitemid 46891039)
31. Kuhn P, Chumanov R, Wang Y, et al. 2011. Automethylation of CARM1 allows coupling of transcription and mRNA splicing. Nucleic Acids Res. 39:2717-26
32. Xu J, Qiu Y, DeMayo FJ, et al. 1998. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279:1922-25 (Pubitemid 28168645)
33. Han SJ, DeMayo FJ, Xu J, et al. 2006. Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor. Mol. Endocrinol. 20:45-55 (Pubitemid 43011669)
34. Xu J, Liao L, Ning G, et al. 2000. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc. Natl. Acad. Sci. USA 97:6379-84 (Pubitemid 30412722)
35. Gehin M, Mark M, Dennefeld C, et al. 2002. The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. Mol. Cell. Biol. 22:5923-37 (Pubitemid 34815840)
36. Mukherjee A, Soyal SM, Fernandez-Valdivia R, et al. 2006. Steroid receptor coactivator 2 is critical for progesterone-dependent uterine function and mammary morphogenesis in the mouse. Mol. Cell. Biol. 26:6571-83 (Pubitemid 44277895)
37. Suzuki A, Horiuchi A, Oka K, et al. 2010. Immunohistochemical detection of steroid receptor cofactors in ovarian endometriosis: involvement of down-regulated SRC-1 expression in the limited growth activity of the endometriotic epithelium. Virchows Arch. 456:433-41
38. Han SJ, Hawkins SM, Begum K, et al. 2012. A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis. Nat. Med. 18:1102-11
39. Dyson MT, Bulun SE. 2012. Cutting SRC-1 down to size in endometriosis. Nat. Med. 18:1016-18
40. Li Y, Low HQ, Foo JN, et al. 2012. Genetic variants in ER cofactor genes and endometrial cancer risk. PLoS One 7:e42445
41. Picard F, Gehin M, Annicotte J, et al. 2002. SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell 111:931-41 (Pubitemid 36044686)
42. Louet JF, Coste A, Amazit L, et al. 2006. Oncogenic steroid receptor coactivator-3 is a key regulator of the white adipogenic program. Proc. Natl. Acad. Sci. USA 103:17868-73 (Pubitemid 44852252)
43. Louet JF, O'Malley BW. 2007. Coregulators in adipogenesis: What could we learn from the SRC (p160) coactivator family? Cell Cycle 6:2448-52 (Pubitemid 350058661)
44. Coste A, Louet JF, Lagouge M, et al. 2008. The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1α. Proc. Natl. Acad. Sci. USA 105:17187- 92
45. Wang Z, Qi C, Krones A, et al. 2006. Critical roles of the p160 transcriptional coactivators p/CIP and SRC-1 in energy balance. Cell Metab. 3:111-22
46. York B, Reineke EL, Sagen JV, et al. 2012. Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy. Cell Metab. 15:752-63
47. Duteil D, Chambon C, Ali F, et al. 2010. The transcriptional coregulators TIF2 and SRC-1 regulate energy homeostasis by modulating mitochondrial respiration in skeletal muscles. Cell Metab. 12:496-508
48. Chen SL, LofflerKA, Chen D, et al. 2002. The coactivator-associated arginine methyltransferase is necessary formuscle differentiation: CARM1coactivates myocyte enhancer factor-2. J. Biol. Chem. 277:4324-33 (Pubitemid 34968698)
49. Wang SC, Dowhan DH, Eriksson NA, et al. 2012. CARM1/PRMT4 is necessary for the glycogen gene expression programme in skeletal muscle cells. Biochem. J. 444:323-31
50. Chopra AR, Louet JF, Saha P, et al. 2008. Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease. Science 322:1395-99 (Pubitemid 352775254)
51. Louet JF, Chopra AR, Sagen JV, et al. 2010. The coactivator SRC-1 is an essential coordinator of hepatic glucose production. Cell Metab. 12:606-18
52. Ferre P, Foufelle F. 2011. A new role for a metabolic star: AMP-activated protein kinase stimulates fat absorption. Cell Metab. 13:1-2
53. Reineke EL, York B, Stashi E, et al. 2012. SRC-2 coactivator deficiency decreases functional reserve in response to pressure overload of mouse heart. PLoS One 7:e53395
54. Wang Z, Shah OJ, Hunter T. 2012. The transcriptional coactivators p/CIP and SRC-1 control insulin resistance through IRS1 in obesity models. PLoS One 7:e36961
55. Qin L, Liu Z, Chen H, et al. 2009. The steroid receptor coactivator-1 regulates Twist expression and promotes breast cancer metastasis. Cancer Res. 69:3819-27
56. McBryan J, Theissen SM, Byrne C, et al. 2012. Metastatic progression with resistance to aromatase inhibitors is driven by the steroid receptor coactivator SRC-1. Cancer Res. 72:548-59
57. McCartan D, Bolger JC, Fagan A, et al. 2012. Global characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine-resistant breast cancer. Cancer Res. 72:220-29
58. Osborne CK, Bardou V, Hopp TA, et al. 2003. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J. Natl. Cancer Inst. 95:353-61 (Pubitemid 36395255)
59. Mann M, Cortez V, Vadlamudi R. 2013. PELP1 oncogenic functions involve CARM1 regulation. Carcinogenesis 34:1468-75
60. Ou CY, LaBonte MJ, Manegold PC, et al. 2011. A coactivator role of CARM1 in the dysregulation of beta-catenin activity in colorectal cancer cell growth and gene expression. Mol. Cancer Res. 9:660-70
61. Cai D, Shames DS, Raso MG, et al. 2010. Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation. Cancer Res. 70:6477-85
62. Taylor BS, Schultz N, Hieronymus H, et al. 2010. Integrative genomic profiling of human prostate cancer. Cancer Cell. 18:11-22
63. Agoulnik IU, Vaid A, Nakka M, et al. 2006. Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer. Cancer Res. 66:10594-602 (Pubitemid 44799783)
64. Agoulnik IU, Weigel NL. 2008. Androgen receptor coactivators and prostate cancer. Adv. Exp.Med. Biol. 617:245-55
65. Shiota M, Yokomizo A, Tada Y, et al. 2010. Peroxisome proliferator-activated receptor gamma coactivator-1alpha interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR. Mol. Endocrinol. 24:114-27
66. Carapeti M, Aguiar RC, Goldman JM, et al. 1998. A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia. Blood 91:3127-33 (Pubitemid 28193860)
67. Carapeti M, Aguiar RC, Watmore AE, et al. 1999. Consistent fusion of MOZ and TIF2 in AML with inv(8) (p11q13). Cancer Genet. Cytogenet. 113:70-72 (Pubitemid 29354097)
68. Fabris S, Mosca L, Cutrona G, et al. 2012. Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia. Am. J. Hematol. 88:24-31
69. Vazquez F, Lim JH, Chim H, et al. 2013. PGC1alpha expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer Cell 23:287-301
70. Dasgupta S, Srinidhi S, Vishwanatha JK. 2012. Oncogenic activation in prostate cancer progression and metastasis: molecular insights and future challenges. J. Carcinog. 11:4
71. Yi P, Xia W, Wu RC, et al. 2013. SRC-3 coactivator regulates cell resistance to cytotoxic stress via TRAF4-mediated p53 destabilization. Genes Dev. 27:274-87
72. Percharde M, Lavial F, Ng JH, et al. 2012. Ncoa3 functions as an essential Esrrb coactivator to sustain embryonic stem cell self-renewal and reprogramming. Genes Dev. 26:2286-98
73. Wu Z, Yang M, Liu H, et al. 2012. Role of Nuclear receptor coactivator 3 (Ncoa3) in pluripotency maintenance. J. Biol. Chem. 287:38295-304
74. O'Malley BW, Kumar R. 2009. Nuclear receptor coregulators in cancer biology. Cancer Res. 69:8217-22
75. Wang Y, Lonard DM, Yu Y, et al. 2011. Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1. Mol. Endocrinol. 25:2041-53
76. O'Malley BW. 2010. Masters of the genome. Nat. Rev. Mol. Cell. Biol. 11:311